[Studies of drugs without randomization (author's transl)]

Area of Science:

• Pharmacovigilance
• Clinical Epidemiology
• Cognitive Science

Background:

• Post-marketing drug surveillance frequently utilizes non-randomized designs.
• Interpreting observational data requires careful consideration of potential biases.
• Distinguishing correlation from causation is a critical challenge in drug safety research.

Purpose of the Study:

• To analyze the cognitive-theoretical differences between controlled clinical trials and epidemiologic studies.
• To identify potential biases in the transition of information from populations to study documentation.
• To clarify the limitations of epidemiologic studies in establishing drug causality.

Main Methods:

• Cognitive theoretical analysis of study designs.
• Comparison of information flow and bias introduction in different research methodologies.
• Literature review on the interpretation of epidemiologic data in drug evaluation.

Main Results:

• Significant cognitive and methodological differences exist between controlled trials and epidemiologic studies.
• Information transfer in epidemiologic studies is susceptible to numerous biases, questioning interpretability.
• Epidemiologic studies are better suited for hypothesis generation rather than definitive causal inference.

Conclusions:

• Epidemiologic studies can reveal population-level differences but struggle to pinpoint drug-specific causal mechanisms.
• The primary value of epidemiologic studies in drug evaluation lies in generating testable hypotheses.
• Rigorous experimental designs, such as controlled trials, are essential for validating drug action hypotheses.